Dick Pluim

5.3k citations
70 papers · 4.2k · 2 hit papers · h-index 30

Impact in

  • Oncology top 0.5%
    • Metal complexes synthesis and properties
    • Drug Transport and Resistance Mechanisms
    • Ferrocene Chemistry and Applications

Papers in

    • Drug Transport and Resistance Mechanisms 14
    • Colorectal Cancer Treatments and Studies 9
    • Cancer Immunotherapy and Biomarkers 6
    • Cancer-related Molecular Pathways 5
    • Cancer therapeutics and mechanisms 13

Dick Pluim

70 papers receiving 4.1k citations

Dick Pluim's Hit Papers

Phase I/II study with ruthenium compound NAMI-A and gemcitabine in patients with non-small cell lung cancer after first line therapy 2014 · 325 citations
3250+7+14Years since publication250500750

Peers

Dick Pluim
Comparison fields: 5 of 115
  • Oncology 2.6k
  • Organic Chemistry 890
  • Biomaterials 397
  • Pediatrics, Perinatology and Child Health 352
  • Molecular Biology 1.4k
Replace Pranav Gupta with:
Pranav Gupta United States
Dong‐Hua Yang United States
K. Mross Germany
Patric J. Jansson Australia
A. Hilary Calvert United Kingdom
Pierantonio Menna Italy
Catherine Booth-Genthe United States
Walter J. Loos Netherlands
Helen M. Coley United Kingdom
Renzo Canetta United States
Dick Pluim relative to Pranav Gupta United States Pranav Gupta's profile →
Citations per field
00.5×1.5×2.5×
Pranav Gupta · 1×
Citations per year

Countries citing papers authored by Dick Pluim

Since Specialization
Citations

This map shows the geographic impact of Dick Pluim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dick Pluim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dick Pluim more than expected).

Fields of papers citing papers by Dick Pluim

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dick Pluim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dick Pluim. The network helps show where Dick Pluim may publish in the future.

Co-authors

The 25 scholars most cited alongside Dick Pluim, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Dick Pluim Line = papers co-authored together Dick Pluim links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 70 papers — load more, or switch the sort, to bring in the rest.

#Work
1
A Phase I and Pharmacological Study with Imidazolium- trans- DMSO-imidazole-tetrachlororuthenate, a Novel Ruthenium Anticancer Agent
Hit paper breakdown →
2004762
2
Overexpression of the BCRP/MXR/ABCP gene in a topotecan-selected ovarian tumor cell line.
1999407
3
Phase I/II study with ruthenium compound NAMI-A and gemcitabine in patients with non-small cell lung cancer after first line therapy
Hit paper breakdown →
2014325
4 2005283
5 2016244
6
Circumvention of breast cancer resistance protein (BCRP)-mediated resistance to camptothecins in vitro using non-substrate drugs or the BCRP inhibitor GF120918.
2001191
7 2004190
8 2004162
9 2004133
10 200293
11 200689
12 200877
13 200477
14 200277
15 201770
16 201861
17 200858
18 201555
19 202051
20 202042

About Dick Pluim

Dick Pluim is a scholar working on Oncology, Molecular Biology, Pulmonary and Respiratory Medicine, Pharmacology and Cancer Research, having authored 70 papers that have together received 4.2k indexed citations. Recurring topics across this work include Drug Transport and Resistance Mechanisms (14 papers), Cancer therapeutics and mechanisms (13 papers), Colorectal Cancer Treatments and Studies (9 papers), Pharmacogenetics and Drug Metabolism (6 papers), Cancer Immunotherapy and Biomarkers (6 papers), Cancer-related Molecular Pathways (5 papers), Chronic Lymphocytic Leukemia Research (5 papers) and Chemotherapy-induced organ toxicity mitigation (4 papers). The work is most often cited by research in Oncology (2.6k citations), Organic Chemistry (890 citations), Biomaterials (397 citations), Pediatrics, Perinatology and Child Health (352 citations) and Molecular Biology (1.4k citations). Dick Pluim has collaborated with scholars based in Netherlands, United States and United Kingdom. Frequent co-authors include Jan H.M. Schellens, Jos H. Beijnen, Jeany M. Rademaker-Lakhai, H.J.G.D. van den Bongard, Marc Maliepaard, Olaf van Tellingen, Pauline Breedveld, Robert C.A.M. van Waardenburg, Matthijs M. Tibben and Alfred H. Schinkel. Their work appears in journals such as Clinical Cancer Research, Cancer Chemotherapy and Pharmacology, Anti-Cancer Drugs, Investigational New Drugs and Analytical and Bioanalytical Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact